US4359465A
(en)
*
|
1980-07-28 |
1982-11-16 |
The Upjohn Company |
Methods for treating gastrointestinal inflammation
|
CH644116A5
(de)
*
|
1980-08-21 |
1984-07-13 |
Hoffmann La Roche |
Imidazolderivate.
|
IL66340A
(en)
*
|
1981-08-13 |
1986-08-31 |
Haessle Ab |
Pharmaceutical compositions comprising pyridylmethyl-thiobenzimidazole derivatives,certain such novel derivatives and their preparation
|
JPS58135881A
(ja)
*
|
1981-11-05 |
1983-08-12 |
ビク−グルデン・ロムベルク・ヘミツシエ・フアブリク・ゲゼルシヤフト・ミト・ベシユレンクテル・ハフツング |
置換ベンズイミダゾ−ル類、その製造方法と利用、およびこれを含む医薬
|
US4472409A
(en)
*
|
1981-11-05 |
1984-09-18 |
Byk Gulden Lomberg Chemische Fabrik Gesellschaft Mit Beschrankter Haftung |
2-Pyridylmethyl thio(sulfinyl)benzimidazoles with gastric acid secretion inhibiting effects
|
DE3216843C2
(de)
*
|
1982-05-05 |
1986-10-23 |
Ludwig Heumann & Co GmbH, 8500 Nürnberg |
3-Thiomethyl-pyridin-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
|
SE8204879D0
(sv)
*
|
1982-08-26 |
1982-08-26 |
Haessle Ab |
Novel chemical intermediates
|
SE8300736D0
(sv)
*
|
1983-02-11 |
1983-02-11 |
Haessle Ab |
Novel pharmacologically active compounds
|
SE8301182D0
(sv)
*
|
1983-03-04 |
1983-03-04 |
Haessle Ab |
Novel compounds
|
HU195220B
(en)
*
|
1983-05-03 |
1988-04-28 |
Byk Gulden Lomberg Chem Fqb |
Process for production of new fluor-alkoxi-benzimidasole-derivatives and medical compositions containig them
|
IL71665A
(en)
*
|
1983-05-03 |
1988-05-31 |
Byk Gulden Lomberg Chem Fab |
Fluoro-(2-pyridyl-methylthio)-dioxolo-(and dioxino-)benzimidazoles,processes for their preparation and pharmaceutical compositions containing the same
|
CA1259070A
(en)
*
|
1983-07-01 |
1989-09-05 |
Upjohn Company (The) |
Substituted 2-¬monoannelated(3,4-,4,5-, and 5,6-)- pyridylalkylenesulfinyl|-benzimidazoles
|
US5077407A
(en)
*
|
1983-07-01 |
1991-12-31 |
The Upjohn Company |
Substituted 2-[monoannelated (3,4-,4,5-, and 5,6-) pyridylalkylenesulfinyl]benzimidazoles
|
DE3333314A1
(de)
*
|
1983-09-15 |
1985-03-28 |
Hoechst Ag, 6230 Frankfurt |
Substituierte pyrido(1,2-c)imidazo(1,2-a)benzimidazole, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen
|
US4663347A
(en)
|
1983-10-31 |
1987-05-05 |
Merck Frosst Canada, Inc. |
Benzofuran 2-carboxylic acid esters useful as inhibitors of leukotriene biosynthesis
|
US4575554A
(en)
*
|
1983-12-05 |
1986-03-11 |
The Upjohn Company |
Substituted 2-pyridylmethylthio- and sulfinyl-benzimidazoles as gastric antisecretory agents
|
ZW4585A1
(en)
*
|
1984-04-19 |
1985-11-20 |
Hoffmann La Roche |
Imidazole derivatives
|
SE8403179D0
(sv)
*
|
1984-06-13 |
1984-06-13 |
Haessle Ab |
New compounds
|
IL75400A
(en)
*
|
1984-06-16 |
1988-10-31 |
Byk Gulden Lomberg Chem Fab |
Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
|
CA1341314C
(en)
|
1984-07-06 |
2001-11-06 |
David Cox |
Derivatives of benzimidazole, benzothiazole and benzoxazole
|
SE8404065D0
(sv)
*
|
1984-08-10 |
1984-08-10 |
Haessle Ab |
Novel biologically active compounds
|
JPS6150979A
(ja)
*
|
1984-08-16 |
1986-03-13 |
Takeda Chem Ind Ltd |
ピリジン誘導体およびその製造法
|
JPS6150978A
(ja)
*
|
1984-08-16 |
1986-03-13 |
Takeda Chem Ind Ltd |
ピリジン誘導体およびその製造法
|
US4619997A
(en)
*
|
1984-09-06 |
1986-10-28 |
The Upjohn Company |
Substituted 2-pyridylmethylthio and sulfinyl-benzimidazoles as gastric antisecretory agents
|
KR890000387B1
(ko)
*
|
1984-09-24 |
1989-03-16 |
디 엎존 캄파니 |
2-(피리딜알켄술 피닐)벤즈 이미드아졸류의 n-치환 유도체의 제조방법
|
SE8405588D0
(sv)
*
|
1984-11-08 |
1984-11-08 |
Haessle Ab |
New compounds
|
EP0187977B1
(en)
*
|
1984-12-18 |
1990-08-29 |
Otsuka Pharmaceutical Co., Ltd. |
Tetrahydroquinoline derivatives, process for preparing the same and anti-peptic ulcer compositions containg the same
|
FI861772A
(fi)
*
|
1985-05-07 |
1986-11-08 |
Chemie Linz Ag |
Nya tieno(2,3-d)imidazolderivat och foerfarande for deras framstaellning.
|
US5869513A
(en)
*
|
1985-05-24 |
1999-02-09 |
G. D. Searle & Co. |
2- (1H-benzimidazol-2-ylsulfinyl)methyl!benzenamines
|
AU5768886A
(en)
|
1985-05-24 |
1986-11-27 |
G.D. Searle & Co. |
2-((1-h-benzimidazol-2-ylsulfinyl)methyl)benzenamines
|
CA1309557C
(en)
|
1985-06-18 |
1992-10-27 |
Robert N. Young |
Leukotriene antagonists
|
US4738975A
(en)
*
|
1985-07-02 |
1988-04-19 |
Takeda Chemical Industries, Ltd. |
Pyridine derivatives, and use as anti-ulcer agents
|
AR243167A1
(es)
|
1985-08-24 |
1993-07-30 |
Hoechst Ag |
Procedimiento para la preparacion de toluidinas sustituidas.
|
JPS6261978A
(ja)
*
|
1985-09-12 |
1987-03-18 |
Otsuka Pharmaceut Co Ltd |
5−フルオロ−1h−ベンズイミダゾ−ル誘導体
|
SE8505112D0
(sv)
*
|
1985-10-29 |
1985-10-29 |
Haessle Ab |
Novel pharmacological compounds
|
US5433959A
(en)
*
|
1986-02-13 |
1995-07-18 |
Takeda Chemical Industries, Ltd. |
Stabilized pharmaceutical composition
|
US6749864B2
(en)
|
1986-02-13 |
2004-06-15 |
Takeda Chemical Industries, Ltd. |
Stabilized pharmaceutical composition
|
CA1327010C
(en)
*
|
1986-02-13 |
1994-02-15 |
Tadashi Makino |
Stabilized solid pharmaceutical composition containing antiulcer benzimidazole compound and its production
|
ES2032394T3
(es)
|
1986-02-20 |
1993-02-16 |
Hoechst Aktiengesellschaft |
Procedimiento para preparar derivados de tienoimidazol sustituidos.
|
WO1987005296A1
(en)
*
|
1986-03-07 |
1987-09-11 |
Pfizer Inc. |
2-[(2-pyridyl)methylsulfinyl]thienoimidazoles and related compounds as antiulcer agents
|
DE3786030T2
(de)
|
1986-03-27 |
1993-12-02 |
Merck Frosst Canada Inc |
Tetrahydrocarbazole Ester.
|
GB2189698A
(en)
*
|
1986-04-30 |
1987-11-04 |
Haessle Ab |
Coated omeprazole tablets
|
GB2189699A
(en)
*
|
1986-04-30 |
1987-11-04 |
Haessle Ab |
Coated acid-labile medicaments
|
US4687775A
(en)
*
|
1986-07-17 |
1987-08-18 |
G. D. Searle & Co. |
2-[(Imidazo[1,2-a]pyridinylmethyl)sulfinyl]-1H-benzimidazoles
|
US4772619A
(en)
*
|
1986-07-17 |
1988-09-20 |
G. D. Searle & Co. |
[(1H-benzimidazol-2-ylsulfinyl)methyl]-2-pyridinamines
|
US4721718A
(en)
*
|
1986-08-18 |
1988-01-26 |
G. D. Searle & Co. |
2-[(imidazo[1,2-a]pyridin-3-ylmethyl)sulfinyl]-1H-benzimidazoles useful in the treatment and prevention of ulcers
|
CA1256109A
(en)
*
|
1986-09-10 |
1989-06-20 |
Franz Rovenszky |
Process for the preparation of derivatives of 4, 5-dihydrooxazoles
|
SE8604566D0
(sv)
*
|
1986-10-27 |
1986-10-27 |
Haessle Ab |
Novel compunds
|
FI90544C
(fi)
*
|
1986-11-13 |
1994-02-25 |
Eisai Co Ltd |
Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi
|
EP0786461A1
(en)
*
|
1986-11-13 |
1997-07-30 |
Eisai Co., Ltd. |
Pyridine derivatives, pharmaceutical compositions comprising the same, the use of the same for the manufacture of medicaments having therapeutic or preventative value, and a process for preparing the same
|
NZ222495A
(en)
|
1986-11-21 |
1991-04-26 |
Haessle Ab |
Benzimidazole derivatives and pharmaceutical compositions
|
SE8604998D0
(sv)
|
1986-11-21 |
1986-11-21 |
Haessle Ab |
Novel pharmacological compounds
|
DE3639926A1
(de)
*
|
1986-11-22 |
1988-06-01 |
Hoechst Ag |
Substituierte thienoimidazoltoluidin-derivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zubereitungen und ihre verwendung als magensaeuresekretionshemmer
|
FI91754C
(fi)
*
|
1986-12-02 |
1994-08-10 |
Tanabe Seiyaku Co |
Analogiamenetelmä lääkeaineena käyttökelpoisen imidatsolijohdannaisen valmistamiseksi
|
JPS63230633A
(ja)
*
|
1987-03-19 |
1988-09-27 |
Nippon Chemiphar Co Ltd |
胃腸の細胞保護剤
|
DE3719783A1
(de)
*
|
1987-06-13 |
1988-12-22 |
Hoechst Ag |
Verfahren zur herstellung von 5-phenylsulfinyl-1h-2-(methoxycarbonylamino)- benzimidazol
|
FI96860C
(fi)
*
|
1987-06-17 |
1996-09-10 |
Eisai Co Ltd |
Analogiamenetelmä lääkeaineena käytettävän pyridiinijohdannaisen valmistamiseksi
|
JP2718945B2
(ja)
*
|
1987-06-17 |
1998-02-25 |
エーザイ株式会社 |
ピリジン誘導体及びそれを含有する潰瘍治療剤
|
DE3723327A1
(de)
*
|
1987-07-15 |
1989-02-02 |
Hoechst Ag |
Substituierte thienoimidazol-derivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zubereitungen und ihre verwendung als magensaeuresekretionshemmer, magenschutzmittel sowie als medikament gegen intestinale entzuendungen
|
DK171989B1
(da)
*
|
1987-08-04 |
1997-09-08 |
Takeda Chemical Industries Ltd |
Fremgangsmåde til fremstilling af 2-(2-pyridylmethylsulfinyl)-benzimidazoler
|
WO1990000054A1
(en)
*
|
1988-06-30 |
1990-01-11 |
The Upjohn Company |
Transdermal antisecretory agents for gastrointestinal disease
|
US5223515A
(en)
*
|
1988-08-18 |
1993-06-29 |
Takeda Chemical Industries, Ltd. |
Injectable solution containing a pyridyl methylsulfinylbenzimidazole
|
AU4057189A
(en)
*
|
1988-08-23 |
1990-03-23 |
Aktiebolaget Hassle |
Treatment of glaucoma and related disorders in the human eye with pyridinylmethyl (sulfinyl or thio)benzimidazoles
|
US5075323A
(en)
*
|
1988-08-24 |
1991-12-24 |
Aktiebolaget Hassle |
Compounds including omeprazole in the treatment of glaucoma
|
AU617217B2
(en)
*
|
1988-09-20 |
1991-11-21 |
Hisamitsu Pharmaceutical Co., Inc. |
Novel dibenz(b,e)oxepin derivatives
|
AT391693B
(de)
*
|
1988-11-15 |
1990-11-12 |
Cl Pharma |
Verfahren zur herstellung von 3-5-dimethyl-4methoxypyridinderivaten sowie neues zwischenprodukt hierfuer
|
SE8804628D0
(sv)
|
1988-12-22 |
1988-12-22 |
Ab Haessle |
New compounds
|
EG19302A
(en)
*
|
1988-12-22 |
1994-11-30 |
Haessle Ab |
Compound with gastric acid inhibitory effect and process for its preparation
|
SE8804629D0
(sv)
*
|
1988-12-22 |
1988-12-22 |
Ab Haessle |
New therapeutically active compounds
|
JP2694361B2
(ja)
*
|
1989-02-09 |
1997-12-24 |
アストラ アクチエボラグ |
抗菌剤
|
GB2239453A
(en)
*
|
1989-11-27 |
1991-07-03 |
Haessle Ab |
Omeprazole
|
US5274099A
(en)
*
|
1989-12-20 |
1993-12-28 |
Aktiebolaget Hassle |
Therapeutically active fluoro substituted benzimidazoles
|
US5049674A
(en)
*
|
1989-12-20 |
1991-09-17 |
Aktiebolaget Hassle |
Therapeutically active fluoro substituted benzimidazoles
|
US4965269A
(en)
*
|
1989-12-20 |
1990-10-23 |
Ab Hassle |
Therapeutically active chloro substituted benzimidazoles
|
KR930000861B1
(ko)
*
|
1990-02-27 |
1993-02-08 |
한미약품공업 주식회사 |
오메프라졸 직장투여 조성물
|
RU2130969C1
(ru)
|
1990-04-04 |
1999-05-27 |
Чирон Корпорейшн |
Композиция для диагностики гепатита c человека (варианты), способ и набор для обнаружения антител к вирусу гепатита c человека
|
SE9002043D0
(sv)
*
|
1990-06-07 |
1990-06-07 |
Astra Ab |
Improved method for synthesis
|
PL165898B1
(pl)
*
|
1990-06-20 |
1995-02-28 |
Astra Ab |
Sposób wytwarzania nowych pochodnych dwualkoksyplrydynylobenzlmldazolu PL
|
SE9002206D0
(sv)
|
1990-06-20 |
1990-06-20 |
Haessle Ab |
New compounds
|
US5061805A
(en)
*
|
1990-08-10 |
1991-10-29 |
Reilly Industries, Inc. |
Process for preparing 2-methyl-3,5-dialkylpyridines by dealkylation with sulfur
|
CA2052698A1
(en)
*
|
1990-10-11 |
1992-04-12 |
Roger G. Berlin |
Treatment of peptic ulcer
|
EP0480716A1
(en)
|
1990-10-12 |
1992-04-15 |
Merck Frosst Canada Inc. |
Saturated hydroxyalkylquinoline acids as leukotriene antagonists
|
CA2053527C
(en)
*
|
1990-10-17 |
2002-03-12 |
Takashi Sohda |
Pyridine derivatives, their production and use
|
ES2026761A6
(es)
*
|
1990-10-31 |
1992-05-01 |
Genesis Para La Investigacion |
Procedimiento de obtencion del omeprazol.
|
NZ244301A
(en)
*
|
1991-09-20 |
1994-08-26 |
Merck & Co Inc |
Preparation of 2-pyridylmethylsulphinylbenzimidazole and pyridoimidazole derivatives from the corresponding sulphenyl compounds
|
WO1995011897A1
(fr)
*
|
1993-10-29 |
1995-05-04 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Compose de pyridine et son utilisation en tant que remede
|
FR2692146B1
(fr)
*
|
1992-06-16 |
1995-06-02 |
Ethypharm Sa |
Compositions stables de microgranules d'omeprazole gastro-protégés et leur procédé d'obtention.
|
CA2138787A1
(en)
*
|
1992-07-08 |
1994-01-20 |
Clifton Augustus Baile |
Alleviating stomach ulcers in swine
|
AU674015B2
(en)
*
|
1992-07-28 |
1996-12-05 |
Astra Aktiebolag |
Injection and injection kit containing omeprazole and its analogs
|
SE9301830D0
(sv)
*
|
1993-05-28 |
1993-05-28 |
Ab Astra |
New compounds
|
US6875872B1
(en)
|
1993-05-28 |
2005-04-05 |
Astrazeneca |
Compounds
|
SE9302396D0
(sv)
*
|
1993-07-09 |
1993-07-09 |
Ab Astra |
A novel compound form
|
SE9302395D0
(sv)
*
|
1993-07-09 |
1993-07-09 |
Ab Astra |
New pharmaceutical formulation
|
US5410054A
(en)
*
|
1993-07-20 |
1995-04-25 |
Merck Frosst Canada, Inc. |
Heteroaryl quinolines as inhibitors of leukotriene biosynthesis
|
TW280770B
(no)
|
1993-10-15 |
1996-07-11 |
Takeda Pharm Industry Co Ltd |
|
US5502195A
(en)
*
|
1993-11-04 |
1996-03-26 |
Slemon; Clarke |
Sulfoxide-carboxylate intermediates of omeprazole and lansoprazole
|
US5374730A
(en)
*
|
1993-11-04 |
1994-12-20 |
Torcan Chemical Ltd. |
Preparation of omeprazole and lansoprazole
|
KR0142815B1
(ko)
*
|
1994-12-02 |
1998-07-15 |
정도언 |
신규한 5-피롤릴-6-할로게노-2피리딜메틸설피닐벤즈이미다졸 유도체
|
KR0179401B1
(ko)
*
|
1994-02-28 |
1999-03-20 |
송택선 |
신규한 5-피롤릴-2-피리딜메틸설피닐벤즈이미다졸 유도체
|
AU2395095A
(en)
|
1994-04-29 |
1995-11-29 |
G.D. Searle & Co. |
Method of using (h+/k+) atpase inhibitors as antiviral agents
|
US5817338A
(en)
|
1994-07-08 |
1998-10-06 |
Astra Aktiebolag |
Multiple unit tableted dosage form of omeprazole
|
SE9402431D0
(sv)
*
|
1994-07-08 |
1994-07-08 |
Astra Ab |
New tablet formulation
|
SE504459C2
(sv)
*
|
1994-07-15 |
1997-02-17 |
Astra Ab |
Förfarande för framställning av substituerade sulfoxider
|
GB9423968D0
(en)
*
|
1994-11-28 |
1995-01-11 |
Astra Ab |
Resolution
|
GB9423970D0
(en)
*
|
1994-11-28 |
1995-01-11 |
Astra Ab |
Oxidation
|
SE9500422D0
(sv)
*
|
1995-02-06 |
1995-02-06 |
Astra Ab |
New oral pharmaceutical dosage forms
|
SE9500478D0
(sv)
*
|
1995-02-09 |
1995-02-09 |
Astra Ab |
New pharmaceutical formulation and process
|
JP3015702B2
(ja)
*
|
1995-02-21 |
2000-03-06 |
株式会社アラクス |
イミダゾール誘導体及びそれらの薬剤として許容される酸付加塩及びその製造法並びにそれらを有効成分とする抗潰瘍剤
|
JP3046924B2
(ja)
*
|
1995-03-27 |
2000-05-29 |
株式会社アラクス |
イミダゾリン誘導体又はそれらの可能な互変異性体及びそれらの製造方法並びにそれらを有効成分とする創傷治療薬
|
US5708017A
(en)
*
|
1995-04-04 |
1998-01-13 |
Merck & Co., Inc. |
Stable, ready-to-use pharmaceutical paste composition containing proton pump inhibitors
|
HRP960232A2
(en)
*
|
1995-07-03 |
1998-02-28 |
Astra Ab |
A process for the optical purification of compounds
|
US5686588A
(en)
*
|
1995-08-16 |
1997-11-11 |
Yoo; Seo Hong |
Amine acid salt compounds and process for the production thereof
|
US5824339A
(en)
*
|
1995-09-08 |
1998-10-20 |
Takeda Chemical Industries, Ltd |
Effervescent composition and its production
|
DE69628444T2
(de)
*
|
1995-09-21 |
2004-05-06 |
Pharma Pass Ii Llc, Irvine |
Säurelabile omeprazol enthaltende pharmazeutische zusammensetzung und verfahren zu dessen herstellung
|
SE521100C2
(sv)
*
|
1995-12-15 |
2003-09-30 |
Astra Ab |
Förfarande för framställning av en bensimidazolförening
|
KR970032861A
(ko)
*
|
1995-12-29 |
1997-07-22 |
김준웅 |
헬리코박터 피로리 제거용 약제 투여방법
|
US5840737A
(en)
|
1996-01-04 |
1998-11-24 |
The Curators Of The University Of Missouri |
Omeprazole solution and method for using same
|
US20050054682A1
(en)
*
|
1996-01-04 |
2005-03-10 |
Phillips Jeffrey O. |
Pharmaceutical compositions comprising substituted benzimidazoles and methods of using same
|
US6645988B2
(en)
|
1996-01-04 |
2003-11-11 |
Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
US6699885B2
(en)
*
|
1996-01-04 |
2004-03-02 |
The Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and methods of using same
|
US6489346B1
(en)
|
1996-01-04 |
2002-12-03 |
The Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
SE9600070D0
(sv)
|
1996-01-08 |
1996-01-08 |
Astra Ab |
New oral pharmaceutical dosage forms
|
WO1997029103A2
(en)
*
|
1996-02-06 |
1997-08-14 |
Pdi-Research Laboratories, Inc. |
Synthesis of omeprazole-type pyridine derivatives and intermediates thereof
|
US6623759B2
(en)
*
|
1996-06-28 |
2003-09-23 |
Astrazeneca Ab |
Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof
|
US5625069A
(en)
*
|
1996-07-22 |
1997-04-29 |
Development Center For Biotechnology |
Process for preparing 2-cyano-3,5-dimethyl-4-methoxypyridine
|
US6380222B2
(en)
|
1996-10-11 |
2002-04-30 |
Astrazeneca Ab |
Use of an H+, K+-atpase inhibitor in the treatment of nasal polyps
|
TW385306B
(en)
*
|
1996-11-14 |
2000-03-21 |
Takeda Chemical Industries Ltd |
Method for producing crystals of benzimidazole derivatives
|
SE510666C2
(sv)
*
|
1996-12-20 |
1999-06-14 |
Astra Ab |
Nya Kristallmodifikationer
|
US6437139B1
(en)
|
1997-05-06 |
2002-08-20 |
Pdi-Research Laboratories, Inc. |
Synthesis of pharmaceutically useful pyridine derivatives
|
CA2204580A1
(en)
*
|
1997-05-06 |
1998-11-06 |
Michel Zoghbi |
Synthesis of pharmaceutically useful pyridine derivatives
|
KR100463031B1
(ko)
*
|
1997-05-26 |
2005-04-06 |
동아제약주식회사 |
5-메톡시-2-[3,5-디메틸-4-메톡시피리딜메틸)설피닐]-1h-벤즈이미다졸의신규제조방법
|
SE9702000D0
(sv)
*
|
1997-05-28 |
1997-05-28 |
Astra Ab |
New pharmaceutical formulation
|
US6051570A
(en)
*
|
1997-05-30 |
2000-04-18 |
Dr. Reddy's Research Foundation |
Benzimidazole derivatives as antiulcer agents, process for their preparation and pharmaceutical compositions containing them
|
SE510650C2
(sv)
|
1997-05-30 |
1999-06-14 |
Astra Ab |
Ny förening
|
US6747155B2
(en)
|
1997-05-30 |
2004-06-08 |
Astrazeneca Ab |
Process
|
SE510643C2
(sv)
|
1997-06-27 |
1999-06-14 |
Astra Ab |
Termodynamiskt stabil omeprazol natrium form B
|
EP0997461B1
(en)
*
|
1997-07-11 |
2003-05-21 |
Eisai Co., Ltd. |
Processes for the preparation of pyridine derivatives
|
SI9700186B
(sl)
|
1997-07-14 |
2006-10-31 |
Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D. |
Nova farmacevtska oblika z nadzorovanim sproscanjem zdravilnih ucinkovin
|
DE69827392T2
(de)
|
1997-07-25 |
2005-10-27 |
Altana Pharma Ag |
Protonenpumpenhemmer als kombinationstherapeutika mit antibakteriell wirkenden substanzen
|
US6296876B1
(en)
|
1997-10-06 |
2001-10-02 |
Isa Odidi |
Pharmaceutical formulations for acid labile substances
|
US7230014B1
(en)
|
1997-10-14 |
2007-06-12 |
Eisai Co., Ltd. |
Pharmaceutical formulation comprising glycine as a stabilizer
|
SE9704183D0
(sv)
|
1997-11-14 |
1997-11-14 |
Astra Ab |
New process
|
US6174548B1
(en)
|
1998-08-28 |
2001-01-16 |
Andrx Pharmaceuticals, Inc. |
Omeprazole formulation
|
US6096340A
(en)
*
|
1997-11-14 |
2000-08-01 |
Andrx Pharmaceuticals, Inc. |
Omeprazole formulation
|
DE69842173D1
(de)
|
1997-12-08 |
2011-04-21 |
Nycomed Gmbh |
Neue Suppositoriumsform mit säureempfindlichem Wirkstoff
|
DE19754324A1
(de)
*
|
1997-12-08 |
1999-06-10 |
Byk Gulden Lomberg Chem Fab |
Neue Darreichungsform enthaltend einen säurelabilen Wirkstoff
|
SE9704870D0
(sv)
*
|
1997-12-22 |
1997-12-22 |
Astra Ab |
New pharmaceutical formulation I
|
SE9704869D0
(sv)
*
|
1997-12-22 |
1997-12-22 |
Astra Ab |
New pharmaceutical formulaton II
|
US6159968A
(en)
*
|
1998-01-15 |
2000-12-12 |
University Of Cincinnati |
Activation of chloride channels for correction of defective chloride transport
|
US6350876B2
(en)
|
1998-01-26 |
2002-02-26 |
Kuraray Co., Ltd. |
4-chloro-3,5-dimethyl-2-sulfonyl pyridines
|
KR100396431B1
(ko)
|
1998-01-26 |
2003-09-02 |
가부시키가이샤 구라레 |
2-술포닐피리딘 유도체 및 2-[((2-피리딜)메틸)티오]-1h-벤즈이
|
IT1299198B1
(it)
|
1998-03-05 |
2000-02-29 |
Nicox Sa |
Sali nitrati di farmaci antiulcera
|
EP2263660B1
(en)
|
1998-05-18 |
2017-09-27 |
Takeda Pharmaceutical Company Limited |
Orally disintegrable tablets
|
US6303787B1
(en)
|
1998-05-27 |
2001-10-16 |
Natco Pharma Limited |
Intermediates and an improved process for the preparation of Omeprazole employing the said intermediates
|
ZA9810765B
(en)
*
|
1998-05-28 |
1999-08-06 |
Ranbaxy Lab Ltd |
Stable oral pharmaceutical composition containing a substituted pyridylsulfinyl benzimidazole.
|
AU4387799A
(en)
*
|
1998-06-26 |
2000-01-17 |
Russinsky Limited |
Pyridine building blocks as intermediates in the synthesis of pharmaceutically active compounds
|
SI20019A
(sl)
*
|
1998-07-13 |
2000-02-29 |
LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. |
Izboljšan postopek sinteze 5-metoksi -2-/(4-metoksi-3,5-dimetil-2-piridil)metil/ sulfinil-1H-benzimidazola
|
US6093734A
(en)
*
|
1998-08-10 |
2000-07-25 |
Partnership Of Michael E. Garst, George Sachs, And Jai Moo Shin |
Prodrugs of proton pump inhibitors
|
AU752292B2
(en)
|
1998-08-10 |
2002-09-12 |
Regents Of The University Of California, The |
Prodrugs of proton pump inhibitors
|
US6191148B1
(en)
*
|
1998-08-11 |
2001-02-20 |
Merck & Co., Inc. |
Omerazole process and compositions thereof
|
US6166213A
(en)
*
|
1998-08-11 |
2000-12-26 |
Merck & Co., Inc. |
Omeprazole process and compositions thereof
|
US7041313B1
(en)
|
1998-08-12 |
2006-05-09 |
Altana Pharma Ag |
Oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazoles
|
DE19843413C1
(de)
*
|
1998-08-18 |
2000-03-30 |
Byk Gulden Lomberg Chem Fab |
Neue Salzform von Pantoprazol
|
US6733778B1
(en)
*
|
1999-08-27 |
2004-05-11 |
Andrx Pharmaceuticals, Inc. |
Omeprazole formulation
|
SE9803772D0
(sv)
|
1998-11-05 |
1998-11-05 |
Astra Ab |
Pharmaceutical formulation
|
AU1054899A
(en)
*
|
1998-11-06 |
2000-05-29 |
Dong-A Pharmaceutical Co., Ltd. |
Method of preparing sulfide derivatives
|
IL142703A
(en)
*
|
1998-11-10 |
2006-04-10 |
Astrazeneca Ab |
Crystalline form of omeprazole
|
UA72748C2
(en)
*
|
1998-11-10 |
2005-04-15 |
Astrazeneca Ab |
A novel crystalline form of omeprazole
|
JP3926936B2
(ja)
*
|
1998-11-16 |
2007-06-06 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
スルホキシド誘導体・アセトン錯体およびその製造法
|
SE9900274D0
(sv)
*
|
1999-01-28 |
1999-01-28 |
Astra Ab |
New compound
|
US6852739B1
(en)
*
|
1999-02-26 |
2005-02-08 |
Nitromed Inc. |
Methods using proton pump inhibitors and nitric oxide donors
|
TWI243672B
(en)
|
1999-06-01 |
2005-11-21 |
Astrazeneca Ab |
New use of compounds as antibacterial agents
|
ATE300285T1
(de)
|
1999-06-07 |
2005-08-15 |
Altana Pharma Ag |
Neue zubereitung und darreichungsform enthaltend einen säurelabilen protonenpumpeninhibitor
|
IL130602A0
(en)
|
1999-06-22 |
2000-06-01 |
Dexcel Ltd |
Stable benzimidazole formulation
|
US6555139B2
(en)
|
1999-06-28 |
2003-04-29 |
Wockhardt Europe Limited |
Preparation of micron-size pharmaceutical particles by microfluidization
|
US6245913B1
(en)
|
1999-06-30 |
2001-06-12 |
Wockhardt Europe Limited |
Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole
|
US6262085B1
(en)
|
1999-08-26 |
2001-07-17 |
Robert R. Whittle |
Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
|
EP1595879A3
(en)
*
|
1999-08-26 |
2010-01-27 |
aaiPharma Inc. |
Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
|
US6312712B1
(en)
|
1999-08-26 |
2001-11-06 |
Robert R. Whittle |
Method of improving bioavailability
|
US6312723B1
(en)
|
1999-08-26 |
2001-11-06 |
Robert R. Whittle |
Pharmaceutical unit dosage form
|
KR100712039B1
(ko)
*
|
1999-08-26 |
2007-04-27 |
에이에이아이파머 인코포레이티드 |
알콕시로 치환된 벤즈이미다졸 화합물, 상기 화합물을포함하는 약학적 제제, 및 상기 화합물의 이용방법
|
KR20020043565A
(ko)
*
|
1999-08-26 |
2002-06-10 |
에이에이아이파머 인코포레이티드 |
조성물에서의 오메프라졸 이성질체 비율의ft-raman 분광학적 측정
|
US6780880B1
(en)
|
1999-08-26 |
2004-08-24 |
Robert R. Whittle |
FT-Raman spectroscopic measurement
|
US6369087B1
(en)
|
1999-08-26 |
2002-04-09 |
Robert R. Whittle |
Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
|
US6262086B1
(en)
|
1999-08-26 |
2001-07-17 |
Robert R. Whittle |
Pharmaceutical unit dosage form
|
US6316020B1
(en)
|
1999-08-26 |
2001-11-13 |
Robert R. Whittle |
Pharmaceutical formulations
|
US6268385B1
(en)
|
1999-08-26 |
2001-07-31 |
Robert R. Whittle |
Dry blend pharmaceutical formulations
|
US6326384B1
(en)
|
1999-08-26 |
2001-12-04 |
Robert R. Whittle |
Dry blend pharmaceutical unit dosage form
|
US6228400B1
(en)
|
1999-09-28 |
2001-05-08 |
Carlsbad Technology, Inc. |
Orally administered pharmaceutical formulations of benzimidazole derivatives and the method of preparing the same
|
SE9903831D0
(sv)
*
|
1999-10-22 |
1999-10-22 |
Astra Ab |
Formulation of substituted benzimidazoles
|
DE19951960C2
(de)
*
|
1999-10-28 |
2002-06-27 |
Gruenenthal Gmbh |
Verfahren zur Herstellung als Ulkustherapeutika geeigneter Benzimidazol-Derivate
|
CA2290893C
(en)
|
1999-11-16 |
2007-05-01 |
Bernard Charles Sherman |
Magnesium omeprazole
|
DE19959419A1
(de)
|
1999-12-09 |
2001-06-21 |
Ratiopharm Gmbh |
Stabile galenische Zubereitungen umfassend ein Benzimidazol und Verfahren zu ihrer Herstellung
|
US20020132819A1
(en)
*
|
1999-12-17 |
2002-09-19 |
Metcalf Chester A. |
Novel purinse
|
US6787342B2
(en)
|
2000-02-16 |
2004-09-07 |
Merial Limited |
Paste formulations
|
SE0000773D0
(sv)
*
|
2000-03-08 |
2000-03-08 |
Astrazeneca Ab |
New formulation
|
SE0000774D0
(sv)
*
|
2000-03-08 |
2000-03-08 |
Astrazeneca Ab |
New formulation
|
US6306435B1
(en)
|
2000-06-26 |
2001-10-23 |
Yung Shin Pharmaceutical Industrial Co. Ltd. |
Oral pharmaceutical preparation embedded in an oily matrix and methods of making the same
|
SE0002476D0
(sv)
|
2000-06-30 |
2000-06-30 |
Astrazeneca Ab |
New compounds
|
US6544556B1
(en)
|
2000-09-11 |
2003-04-08 |
Andrx Corporation |
Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor
|
US20020064555A1
(en)
*
|
2000-09-29 |
2002-05-30 |
Dan Cullen |
Proton pump inhibitor formulation
|
EP1341528B1
(en)
|
2000-12-07 |
2012-01-18 |
Nycomed GmbH |
Rapidly disintegrating tablet comprising an acid-labile active ingredient
|
KR20030059318A
(ko)
|
2000-12-07 |
2003-07-07 |
알타나 파마 아게 |
산 불안정성 활성 성분을 포함하는 현탁액 형태의 약학 제제
|
ES2375269T3
(es)
|
2000-12-07 |
2012-02-28 |
Nycomed Gmbh |
Preparado farmacéutico en forma de una pasta que comprende un ingrediente activo l�?bil ante los �?cidos.
|
ES2209678T1
(es)
|
2001-02-02 |
2004-07-01 |
Teva Pharmaceutical Industries Ltd. |
Procedimientos para proporcionar 2-(2-piridilmetil)sulfonil-1h-benzimidazoles sustituidos.
|
US6645946B1
(en)
|
2001-03-27 |
2003-11-11 |
Pro-Pharmaceuticals, Inc. |
Delivery of a therapeutic agent in a formulation for reduced toxicity
|
SE0101379D0
(sv)
|
2001-04-18 |
2001-04-18 |
Diabact Ab |
Komposition som hämmar utsöndring av magsyra
|
SI20875A
(sl)
*
|
2001-04-25 |
2002-10-31 |
LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. |
Kristalna oblika omeprazola
|
JP4756823B2
(ja)
*
|
2001-06-01 |
2011-08-24 |
ポーゼン インコーポレイテッド |
Nsaidを協調的に送達するための薬剤組成物
|
US8206741B2
(en)
|
2001-06-01 |
2012-06-26 |
Pozen Inc. |
Pharmaceutical compositions for the coordinated delivery of NSAIDs
|
DE10140492A1
(de)
|
2001-08-17 |
2003-08-14 |
Gruenenthal Gmbh |
Hydrate von gegebenenfalls substituierten 2-(2-Pyridinyl)methylthio-1H-benzimidazolen und Verfahren zu ihrer Herstellung
|
SE0102993D0
(sv)
|
2001-09-07 |
2001-09-07 |
Astrazeneca Ab |
New self emulsifying drug delivery system
|
CA2445513A1
(en)
*
|
2001-09-18 |
2003-03-27 |
Zeria Pharmaceutical Co., Ltd. |
Benzimidazole derivatives
|
US8101209B2
(en)
|
2001-10-09 |
2012-01-24 |
Flamel Technologies |
Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
|
DK1459737T3
(da)
|
2001-10-17 |
2013-01-02 |
Takeda Pharmaceutical |
Granulat indeholdende syreustabilt kemisk middel i stor mængde
|
US7855082B1
(en)
|
2001-10-31 |
2010-12-21 |
Astrazeneca Ab |
Raman spectroscopic method for determining the ratio of 5-methoxy and 6-methoxy isomers of omeprazole
|
EP1469839A2
(en)
*
|
2002-01-25 |
2004-10-27 |
Santarus, Inc. |
Transmucosal delivery of proton pump inhibitors
|
WO2003074514A1
(en)
|
2002-03-05 |
2003-09-12 |
Astrazeneca Ab |
Alkylammonium salts of omeprazole and esomeprazole
|
US7910133B2
(en)
|
2002-04-09 |
2011-03-22 |
Flamel Technologies |
Oral pharmaceutical formulation in the form of aqueous suspension of microcapsules for modified release of amoxicillin
|
US7906145B2
(en)
|
2002-04-09 |
2011-03-15 |
Flamel Technologies |
Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s)
|
US20030228363A1
(en)
*
|
2002-06-07 |
2003-12-11 |
Patel Mahendra R. |
Stabilized pharmaceutical compositons containing benzimidazole compounds
|
US20040034078A1
(en)
*
|
2002-06-14 |
2004-02-19 |
Agouron Pharmaceuticals, Inc. |
Benzimidazole inhibitors of poly(ADP-ribosyl) polymerase
|
BR0312802A
(pt)
*
|
2002-07-19 |
2005-04-19 |
Michael E Garst |
Pró-drogas de inibidores de bombas de próton
|
TW200410955A
(en)
|
2002-07-29 |
2004-07-01 |
Altana Pharma Ag |
Novel salt of (S)-PANTOPRAZOLE
|
JP4634144B2
(ja)
*
|
2002-08-01 |
2011-02-16 |
ニコックス エスエー |
ニトロソ化プロトンポンプ阻害剤、組成物および使用方法
|
SE0203065D0
(sv)
|
2002-10-16 |
2002-10-16 |
Diabact Ab |
Gastric acid secretion inhibiting composition
|
MY148805A
(en)
|
2002-10-16 |
2013-05-31 |
Takeda Pharmaceutical |
Controlled release preparation
|
CA2502219C
(en)
|
2002-10-16 |
2012-05-29 |
Takeda Pharmaceutical Company Limited |
A process for producing an amorphous isomer of lansoprazole
|
SE0203092D0
(en)
*
|
2002-10-18 |
2002-10-18 |
Astrazeneca Ab |
Method for the synthesis of a benzimidazole compound
|
FR2845915B1
(fr)
|
2002-10-21 |
2006-06-23 |
Negma Gild |
Utilisation du tenatoprazole pour le traitement du reflux gastro-oesophagien
|
BR0315574A
(pt)
*
|
2002-10-22 |
2005-09-20 |
Ranbaxy Lab Ltd |
Forma amorfa de esomeprazol, composição farmacêutica contendo o mesmo e processo para sua preparação
|
DE10254167A1
(de)
|
2002-11-20 |
2004-06-09 |
Icon Genetics Ag |
Verfahren zur Kontrolle von zellulären Prozessen in Pflanzen
|
DK1578742T3
(da)
|
2002-12-06 |
2013-01-21 |
Nycomed Gmbh |
Fremgangsmåde til fremstilling af optisk rene aktive forbindelser
|
SI1575941T1
(sl)
|
2002-12-06 |
2012-08-31 |
Nycomed Gmbh |
Postopek za pripravo (S)-pantoprazola
|
FR2848555B1
(fr)
|
2002-12-16 |
2006-07-28 |
Negma Gild |
Enantiomere(-)du tenatoprazole et son application en therapeutique
|
JP2006514108A
(ja)
*
|
2002-12-19 |
2006-04-27 |
テバ ファーマシューティカル インダストリーズ リミティド |
パントプラゾールナトリウムの固体状態、それらの調製方法、及び公知のパントプラゾールナトリウム水和物の調製方法
|
US20040166162A1
(en)
*
|
2003-01-24 |
2004-08-26 |
Robert Niecestro |
Novel pharmaceutical formulation containing a proton pump inhibitor and an antacid
|
TWI367759B
(en)
*
|
2003-02-20 |
2012-07-11 |
Santarus Inc |
A novel formulation, omeprazole antacid complex-immediate release, for rapid and sustained suppression of gastric acid
|
US20040185119A1
(en)
*
|
2003-02-26 |
2004-09-23 |
Theuer Richard C. |
Method and compositions for treating gastric hyperacidity while diminishing the likelihood of producing vitamin deficiency
|
EP1601667A2
(en)
*
|
2003-03-12 |
2005-12-07 |
Teva Pharmaceutical Industries Limited |
Crystalline and amorphous solids of pantoprazole and processes for their preparation
|
EP1611901B1
(en)
*
|
2003-03-13 |
2013-07-10 |
Eisai R&D Management Co., Ltd. |
Preventive or remedy for teeth grinding
|
US20040185092A1
(en)
*
|
2003-03-18 |
2004-09-23 |
Yih Ming Hsiao |
Pharmaceutical preparations of omeprazole and/or clarithromycin for oral use
|
JP2006523201A
(ja)
*
|
2003-03-28 |
2006-10-12 |
シデム ファーマ |
スルホキシド誘導体をエナンチオ選択的に調製する方法
|
FR2852956B1
(fr)
*
|
2003-03-28 |
2006-08-04 |
Negma Gild |
Procede de preparation enantioselective de derives de sulfoxydes
|
CL2004000983A1
(es)
|
2003-05-08 |
2005-03-04 |
Altana Pharma Ag |
Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y
|
PE20050150A1
(es)
|
2003-05-08 |
2005-03-22 |
Altana Pharma Ag |
Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo
|
WO2004101533A1
(en)
*
|
2003-05-12 |
2004-11-25 |
Janssen Pharmaceutica, N.V. |
1, 3, 4-benzotriazepin-2-one salts and their use as cck receptor ligands
|
MXPA05013316A
(es)
*
|
2003-06-10 |
2006-03-17 |
Teva Pharma |
Proceso para preparar bencimidazoles 2[-(piridinil)metil]sulfinil-sustituidos y derivados clorados novedosos de pantoprazol.
|
CA2529984C
(en)
*
|
2003-06-26 |
2012-09-25 |
Isa Odidi |
Oral multi-functional pharmaceutical capsule preparations of proton pump inhibitors
|
WO2005016917A1
(en)
*
|
2003-07-15 |
2005-02-24 |
Allergan, Inc. |
Process for preparing isomerically pure prodrugs of proton pump inhibitors
|
EP1648417A4
(en)
*
|
2003-07-18 |
2010-01-20 |
Santarus Inc |
PHARMACEUTICAL FORMULATION AND METHOD FOR THE TREATMENT OF GASTROINTESTINAL ACIDITY RELATED DISORDERS
|
TWI398273B
(zh)
*
|
2003-07-18 |
2013-06-11 |
Santarus Inc |
用於抑制酸分泌之醫藥調配物及其製備及使用之方法
|
US8993599B2
(en)
|
2003-07-18 |
2015-03-31 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
JP2007504261A
(ja)
*
|
2003-09-03 |
2007-03-01 |
エイジーアイ・セラピューティクス・リサーチ・リミテッド |
プロトンポンプ阻害剤製剤、並びに当該製剤を製造及び使用する方法関連出願の表示
|
SE0302382D0
(sv)
|
2003-09-04 |
2003-09-04 |
Astrazeneca Ab |
New salts II
|
SE0302381D0
(sv)
|
2003-09-04 |
2003-09-04 |
Astrazeneca Ab |
New salts I
|
TWI372066B
(en)
|
2003-10-01 |
2012-09-11 |
Wyeth Corp |
Pantoprazole multiparticulate formulations
|
US20050075371A1
(en)
*
|
2003-10-03 |
2005-04-07 |
Allergan, Inc. |
Methods and compositions for the oral administration of prodrugs of proton pump inhibitors
|
WO2005039640A1
(en)
*
|
2003-10-03 |
2005-05-06 |
Allergan Inc. |
Compositions comprising trefoil factor family peptides and/or mucoadhesives and proton pump inhibitor prodrugs
|
BRPI0415533A
(pt)
*
|
2003-10-24 |
2006-12-26 |
Immunaid Pty Ltd |
método de terapia
|
US20070292498A1
(en)
*
|
2003-11-05 |
2007-12-20 |
Warren Hall |
Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
|
EP1716136A1
(en)
|
2004-02-11 |
2006-11-02 |
Ulkar Kimya Sanayii Ve Ticaret A.S. |
Pyridine benzimidazole sulfoxides of high purity
|
BRPI0507837A
(pt)
*
|
2004-02-18 |
2007-07-10 |
Allergan Inc |
métodos e composições para a administração intravenosa de compostos relacionados a inibidores de bomba de prótons
|
BRPI0507784A
(pt)
*
|
2004-02-18 |
2007-07-17 |
Allergan Inc |
métodos e composições para a administração de pró-fármacos de inibidores da bomba de prótons
|
SE0400410D0
(sv)
|
2004-02-20 |
2004-02-20 |
Astrazeneca Ab |
New compounds
|
US20080287502A1
(en)
*
|
2004-03-30 |
2008-11-20 |
Dermatrends, Inc. |
Transdermal Administration of Proton Pump Inhibitors
|
PT1740571E
(pt)
|
2004-04-28 |
2009-09-02 |
Hetero Drugs Ltd |
Processo para preparar compostos de piridinilmetil-1hbenzimidazol na forma enantiomericamente enriquecida ou como enantiómeros únicos
|
US8906940B2
(en)
|
2004-05-25 |
2014-12-09 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
US8815916B2
(en)
|
2004-05-25 |
2014-08-26 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
US20050267157A1
(en)
*
|
2004-05-28 |
2005-12-01 |
David White |
Magnesium-S-omeprazole
|
EP1748998B1
(en)
|
2004-05-28 |
2010-01-27 |
Hetero Drugs Limited |
A novel stereoselective synthesis of benzimidazole sulfoxides
|
BRPI0511515A
(pt)
*
|
2004-06-02 |
2007-12-26 |
Altana Pharma Ag |
processo para a preparação de compostos de piridin-2-ilmetilsulfinil-1h-benzimidazol
|
US8394409B2
(en)
|
2004-07-01 |
2013-03-12 |
Intellipharmaceutics Corp. |
Controlled extended drug release technology
|
US20060024362A1
(en)
*
|
2004-07-29 |
2006-02-02 |
Pawan Seth |
Composition comprising a benzimidazole and process for its manufacture
|
US10624858B2
(en)
|
2004-08-23 |
2020-04-21 |
Intellipharmaceutics Corp |
Controlled release composition using transition coating, and method of preparing same
|
CA2579665C
(en)
|
2004-09-13 |
2014-03-18 |
Takeda Pharmaceutical Company Limited |
Method and apparatus for producing oxidized compound
|
US8541026B2
(en)
|
2004-09-24 |
2013-09-24 |
Abbvie Inc. |
Sustained release formulations of opioid and nonopioid analgesics
|
EP2417986A1
(en)
|
2004-11-22 |
2012-02-15 |
Anadis Ltd. |
Bioactive compositions
|
EP1830823A2
(en)
|
2004-12-23 |
2007-09-12 |
Ranbaxy Laboratories Limited |
Stable oral benzimidazole compositions and process of preparation thereof
|
EP1845982A2
(en)
*
|
2005-02-02 |
2007-10-24 |
Ranbaxy Laboratories Limited |
Stable oral benzimidazole compositions prepared by non-aqueous layering process
|
US8871273B2
(en)
|
2005-02-25 |
2014-10-28 |
Takeda Pharmaceutical Company Limited |
Method for producing granules
|
US7803817B2
(en)
|
2005-05-11 |
2010-09-28 |
Vecta, Ltd. |
Composition and methods for inhibiting gastric acid secretion
|
US7981908B2
(en)
|
2005-05-11 |
2011-07-19 |
Vecta, Ltd. |
Compositions and methods for inhibiting gastric acid secretion
|
EP1891043A1
(en)
|
2005-06-15 |
2008-02-27 |
Hetero Drugs Limited |
Amorphous esomeprazole hydrate
|
US20080200533A1
(en)
*
|
2005-07-04 |
2008-08-21 |
Ramu Krishnan |
Drug or Pharmaceutical Compounds and a Preparation Thereof
|
EP1904064A4
(en)
*
|
2005-07-07 |
2009-12-02 |
Reddys Lab Ltd Dr |
OMEPRAZOLE OF FORM B
|
US7601737B2
(en)
*
|
2005-07-26 |
2009-10-13 |
Nycomed Gmbh |
Isotopically substituted proton pump inhibitors
|
WO2007012651A1
(en)
*
|
2005-07-26 |
2007-02-01 |
Nycomed Gmbh |
Isotopically substituted pantoprazole
|
AR054584A1
(es)
*
|
2005-07-26 |
2007-06-27 |
Altana Pharma Ag |
Inhibidores de la bomba de protones isotopicamente sustituidos
|
US7598273B2
(en)
|
2005-10-06 |
2009-10-06 |
Auspex Pharmaceuticals, Inc |
Inhibitors of the gastric H+, K+-ATPase with enhanced therapeutic properties
|
US7576219B2
(en)
|
2005-10-26 |
2009-08-18 |
Hanmi Pharm. Co., Ltd |
Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing same
|
NZ568471A
(en)
|
2005-12-05 |
2010-09-30 |
Astrazeneca Ab |
New process for the preparation of esomeprazole non-salt form
|
EP1801110A1
(en)
|
2005-12-22 |
2007-06-27 |
KRKA, tovarna zdravil, d.d., Novo mesto |
Esomeprazole arginine salt
|
US10064828B1
(en)
|
2005-12-23 |
2018-09-04 |
Intellipharmaceutics Corp. |
Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
|
KR101289215B1
(ko)
|
2005-12-28 |
2013-07-29 |
유니온 퀴미코 파르마세우티카, 에스.에이. |
오메프라졸의 (에스)-엔안티오머의 제조 방법
|
CA2634232C
(en)
|
2005-12-28 |
2013-08-20 |
Takeda Pharmaceutical Company Limited |
Method of producing solid preparation disintegrating in the oral cavity
|
JP5457830B2
(ja)
*
|
2006-04-03 |
2014-04-02 |
オディディ,イサ |
オルガノゾル被膜を含む制御放出送達デバイス
|
US10960077B2
(en)
|
2006-05-12 |
2021-03-30 |
Intellipharmaceutics Corp. |
Abuse and alcohol resistant drug composition
|
US7786309B2
(en)
|
2006-06-09 |
2010-08-31 |
Apotex Pharmachem Inc. |
Process for the preparation of esomeprazole and salts thereof
|
US7863330B2
(en)
|
2006-06-14 |
2011-01-04 |
Rottapharm S.P.A. |
Deloxiglumide and proton pump inhibitor combination in the treatment of gastrointestinal disorders
|
EP2046334B1
(en)
|
2006-07-25 |
2014-05-21 |
Vecta Ltd. |
Compositions and meth0ds for inhibiting gastric acide secretion using derivatives of small dicarboxylic acids in combination with ppi
|
WO2008036201A1
(en)
*
|
2006-09-19 |
2008-03-27 |
Alevium Pharmaceuticals, Inc. |
Prodrugs of proton pump inhibitors including the 1h-imidazo[4,5-b] pyridine moiety
|
US20090092658A1
(en)
*
|
2007-10-05 |
2009-04-09 |
Santarus, Inc. |
Novel formulations of proton pump inhibitors and methods of using these formulations
|
CA2665226C
(en)
|
2006-10-05 |
2014-05-13 |
Santarus, Inc. |
Novel formulations of proton pump inhibitors and methods of using these formulations
|
US20080103169A1
(en)
|
2006-10-27 |
2008-05-01 |
The Curators Of The University Of Missouri |
Compositions comprising acid labile proton pump inhibiting agents, at least one other pharmaceutically active agent and methods of using same
|
NZ578204A
(en)
|
2006-12-22 |
2012-05-25 |
Ironwood Pharmaceuticals Inc |
Compositions comprising bile acid sequestrants for treating esophageal disorders
|
EP1947099A1
(en)
|
2007-01-18 |
2008-07-23 |
LEK Pharmaceuticals D.D. |
Process for solvent removal from omeprazole salts
|
EP2114919A2
(en)
|
2007-01-31 |
2009-11-11 |
Krka Tovarna Zdravil, D.D., Novo Mesto |
Process for the preparation of optically pure omeprazole via salt formation with a chiral amine or treatment with an entiomer converting enzyme and chromatographic seperation
|
US20080194307A1
(en)
*
|
2007-02-13 |
2008-08-14 |
Jeff Sanger |
Sports-based game of chance
|
AU2008217603C1
(en)
*
|
2007-02-21 |
2013-08-15 |
Cipla Limited |
Process for the preparation of esomeprazole magnesium dihydrate
|
CA2679741A1
(en)
*
|
2007-03-15 |
2008-09-18 |
Sun Pharma Advanced Research Company Ltd. |
Novel prodrugs
|
ATE534643T1
(de)
*
|
2007-06-07 |
2011-12-15 |
Aurobindo Pharma Ltd |
Verbessertes verfahren zur herstellung eines optisch aktiven protonenpumpenhemmers
|
WO2009010937A1
(en)
*
|
2007-07-17 |
2009-01-22 |
Ranbaxy Laboratories Limited |
Process for the preparation op pantoprazole sodium and pantoprazole sodium sesquihydrate
|
WO2009066317A2
(en)
*
|
2007-08-20 |
2009-05-28 |
Macleods Pharmaceuticals Limited |
Process for the preparation of pantoprazole sodium
|
US8106210B2
(en)
|
2007-10-08 |
2012-01-31 |
Hetero Drugs Limited |
Polymorphs of esomeprazole salts
|
CN101450939B
(zh)
*
|
2007-12-05 |
2013-06-19 |
沈阳药科大学 |
新型苯并咪唑类化合物
|
JP2011512416A
(ja)
|
2008-02-20 |
2011-04-21 |
ザ・キュレイターズ・オブ・ザ・ユニバーシティー・オブ・ミズーリ |
オメプラゾール及びランソプラゾールの組合せと緩衝剤を含んでなる組成物とそれを使用する方法
|
US8911787B2
(en)
|
2008-02-26 |
2014-12-16 |
Ranbaxy Laboratories Limited |
Stable oral benzimidazole compositions and process of preparation thereof
|
WO2009129300A2
(en)
*
|
2008-04-15 |
2009-10-22 |
Schering Corporation |
High density compositions containing posaconazole and formulations comprising the same
|
EP2278957A2
(en)
*
|
2008-04-15 |
2011-02-02 |
Schering Corporation |
Oral pharmaceutical compositions in a solid dispersion comprising preferably posaconazole and hpmcas
|
KR101044880B1
(ko)
*
|
2008-06-12 |
2011-06-28 |
일양약품주식회사 |
항궤양제 화합물의 합성에 유용한 중간체의 제조방법
|
EP2147918A1
(en)
|
2008-07-21 |
2010-01-27 |
LEK Pharmaceuticals D.D. |
Process for the preparation of S-omeprazole magnesium in a stable form
|
CH699302B1
(de)
*
|
2008-08-11 |
2012-03-15 |
Mepha Gmbh |
Orale pharmazeutische Formulierung für Omeprazol, enthaltend eine spezifische Trennschicht.
|
CN102209529A
(zh)
|
2008-09-09 |
2011-10-05 |
阿斯利康(瑞典)有限公司 |
将药物组合物递送至有需要的患者的方法
|
WO2010042785A1
(en)
*
|
2008-10-10 |
2010-04-15 |
Celtaxsys, Inc. |
Method of inducing negative chemotaxis
|
EP2264024A1
(en)
|
2008-10-14 |
2010-12-22 |
LEK Pharmaceuticals d.d. |
Process for the preparation of enantiomerically enriched proton pump inhibitors
|
WO2010134099A1
(en)
|
2009-05-21 |
2010-11-25 |
Cadila Healthcare Limited |
One pot process for preparing omeprazole and related compounds
|
EP2435825B8
(en)
|
2009-05-27 |
2015-09-02 |
Biotempus Limited |
Methods of treating diseases
|
EP2445499A4
(en)
|
2009-06-25 |
2013-02-27 |
Astrazeneca Ab |
METHOD FOR TREATING A PATIENT WITH RISK OF DEVELOPING A NSAID-ASSOCIATED SPURGE
|
CA2766524A1
(en)
*
|
2009-06-25 |
2010-12-29 |
Pozen Inc. |
Method for treating a patient in need of aspirin therapy
|
WO2011058569A1
(en)
|
2009-11-12 |
2011-05-19 |
Hetero Research Foundation |
Process for the resolution of omeprazole
|
WO2011080502A2
(en)
|
2009-12-29 |
2011-07-07 |
Orexo Ab |
New pharmaceutical dosage form for the treatment of gastric acid-related disorders
|
WO2011080500A2
(en)
|
2009-12-29 |
2011-07-07 |
Orexo Ab |
New pharmaceutical dosage form for the treatment of gastric acid-related disorders
|
US20120294937A1
(en)
|
2009-12-29 |
2012-11-22 |
Novartis Ag |
New pharmaceutical dosage form for the treatment of gastric acid-related disorders
|
EP2345408A3
(en)
|
2010-01-08 |
2012-02-29 |
Dr. Reddy's Laboratories Ltd. |
Acid labile drug formulations
|
CN102140099A
(zh)
|
2010-02-02 |
2011-08-03 |
山东轩竹医药科技有限公司 |
新的吡啶衍生物
|
US9623622B2
(en)
*
|
2010-02-24 |
2017-04-18 |
Michael Baines |
Packaging materials and methods
|
US20130156720A1
(en)
|
2010-08-27 |
2013-06-20 |
Ironwood Pharmaceuticals, Inc. |
Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
|
US9233103B2
(en)
|
2011-03-25 |
2016-01-12 |
Takeda Pharmaceuticals U.S.A., Inc. |
Methods for treating heartburn, gastric bleeding or hemorrhage in patients receiving clopidogrel therapy
|
WO2013031620A1
(ja)
|
2011-08-26 |
2013-03-07 |
国立大学法人名古屋大学 |
骨形成促進剤及びその用途
|
WO2013036783A2
(en)
|
2011-09-09 |
2013-03-14 |
Cubist Pharmaceuticals, Inc. |
Methods for treating intrapulmonary infections
|
WO2013081566A1
(en)
|
2011-11-25 |
2013-06-06 |
Mahmut Bilgic |
A formulation comprising benzimidazole
|
EP2601947A1
(en)
|
2011-12-05 |
2013-06-12 |
Abo Bakr Mohammed Ali Al-Mehdar |
Fixed-dose combination for treatment of helicobacter pylori associated diseases
|
WO2013101897A2
(en)
|
2011-12-28 |
2013-07-04 |
Pozen Inc. |
Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid
|
CN102584792B
(zh)
*
|
2012-01-06 |
2014-06-11 |
南京优科生物医药研究有限公司 |
制备高纯度的埃索美拉唑盐的方法
|
CN104203938A
(zh)
|
2012-01-21 |
2014-12-10 |
朱比兰特生命科学有限公司 |
用于制备2-吡啶基甲基亚硫酰基苯并咪唑、它们的类似物和光学活性对映体的方法
|
US8809314B1
(en)
|
2012-09-07 |
2014-08-19 |
Cubist Pharmacueticals, Inc. |
Cephalosporin compound
|
US8476425B1
(en)
|
2012-09-27 |
2013-07-02 |
Cubist Pharmaceuticals, Inc. |
Tazobactam arginine compositions
|
US20160015644A1
(en)
|
2013-01-15 |
2016-01-21 |
Ironwood Pharmaceuticals, Inc. |
Gastro-retentive sustained-release oral dosage form of a bile acid sequestrant
|
US9872906B2
(en)
|
2013-03-15 |
2018-01-23 |
Merck Sharp & Dohme Corp. |
Ceftolozane antibiotic compositions
|
CA2906151A1
(en)
|
2013-03-15 |
2014-09-18 |
Merck Sharp & Dohme Corp. |
Ceftolozane antibiotic compositions
|
US20140274997A1
(en)
|
2013-03-15 |
2014-09-18 |
Cubist Pharmaceuticals, Inc. |
Cephalosporin pharmaceutical compositions
|
GB201306720D0
(en)
|
2013-04-12 |
2013-05-29 |
Special Products Ltd |
Formulation
|
WO2015035376A2
(en)
|
2013-09-09 |
2015-03-12 |
Calixa Therapeutics, Inc. |
Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
|
US8906898B1
(en)
|
2013-09-27 |
2014-12-09 |
Calixa Therapeutics, Inc. |
Solid forms of ceftolozane
|
US9457011B2
(en)
|
2014-02-25 |
2016-10-04 |
Muslim D. Shahid |
Compositions and methods for the treatment of acid-related gastrointestinal disorders containing a dithiolane compound and a gastric acid secretion inhibitor
|
FR3018812A1
(fr)
|
2014-03-21 |
2015-09-25 |
Minakem |
Nouvelle phase intermediaire de la forme a du sel de magnesium dihydrate d'un enantiomere de l'omeprazole
|
WO2015155307A1
(en)
|
2014-04-11 |
2015-10-15 |
Sanovel Ilac Sanayi Ve Ticaret A.S. |
Pharmaceutical combinations of rivaroxaban and proton pump inhibitors
|
EP2933002A1
(en)
|
2014-04-11 |
2015-10-21 |
Sanovel Ilac Sanayi ve Ticaret A.S. |
Pharmaceutical combinations of dabigatran and proton pump inhibitors
|
CN104045627A
(zh)
*
|
2014-05-21 |
2014-09-17 |
丽珠医药集团股份有限公司 |
一种奥美拉唑纯化方法
|
US10548911B2
(en)
|
2014-06-16 |
2020-02-04 |
University Of Rochester |
Small molecule anti-scarring agents
|
US20180015118A1
(en)
|
2015-02-03 |
2018-01-18 |
Ironwood Pharmaceuticals, Inc. |
Methods of treating upper gastrointestinal disorders in ppi refractory gerd
|
WO2016174664A1
(en)
|
2015-04-29 |
2016-11-03 |
Dexcel Pharma Technologies Ltd. |
Orally disintegrating compositions
|
WO2017145146A1
(en)
|
2016-02-25 |
2017-08-31 |
Dexcel Pharma Technologies Ltd. |
Compositions comprising proton pump inhibitors
|
US10076494B2
(en)
|
2016-06-16 |
2018-09-18 |
Dexcel Pharma Technologies Ltd. |
Stable orally disintegrating pharmaceutical compositions
|
KR102419769B1
(ko)
*
|
2016-08-11 |
2022-07-13 |
아다미스 파마슈티칼스 코포레이션 |
약물 조성물
|
EP3292862A1
(en)
|
2016-09-07 |
2018-03-14 |
Sandoz Ag |
Omeprazole formulations
|
TWI659022B
(zh)
*
|
2016-09-14 |
2019-05-11 |
國立臺灣大學 |
作為d-胺基酸氧化酶(daao)抑制劑之新穎經取代苯并咪唑衍生物
|
WO2019113493A1
(en)
|
2017-12-08 |
2019-06-13 |
Adamis Pharmaceuticals Corporation |
Drug compositions
|
CN110317164B
(zh)
*
|
2019-07-06 |
2022-08-19 |
抚州三和医药化工有限公司 |
一种奥美拉唑中间体的制备方法
|
US20220257597A1
(en)
|
2021-01-29 |
2022-08-18 |
Abbvie Inc. |
Methods of Administering Elagolix
|
WO2024075017A1
(en)
|
2022-10-04 |
2024-04-11 |
Zabirnyk Arsenii |
Inhibition of aortic valve calcification
|